课件：梅尼埃病上海交通大学医学院.ppt

梅尼埃病,上海交通大学医学院附属新华医院耳鼻咽喉-头颈外科 上海交通大学医学院耳科学研究所 上海交通大学医学院耳鼻咽喉科学系 杨 军,定 义,以发作性眩晕、波动性耳聋、耳鸣、耳内闷 胀感为主要症状的疾病。,历 史,1861 Prosper Meniere叙述了其典型症状，将此病病因归因于迷路 1871 Knappin膜迷路膨胀理论 1938 Hallpike 和Portmann通过颞骨组织学证实与内淋巴积液有关 1972 AAOO 定义此病标准 1985 AAO-HNS修正定义并建立报告草案 1995 AAO-HNS再次修正定义和报告草案,生理学,外淋巴 位于前庭阶和鼓阶 与脑脊液成分类似 高Na+, 低 K+ 内淋巴 位于中阶 与细胞内液成分类似 低Na+ 高 K+ 由血管纹产生 膜迷路分离此间隔 无压力差别,病理生理学,内淋巴积液导致膜迷路变形 在一些组织学研究中Reisners 膜突入前庭阶 ？,病理生理学,内淋巴积液背后的理论 内淋巴管/囊阻塞 内淋巴管/囊发育不全 内淋巴吸收功能改变 内淋巴生成改变 自身免疫损伤 血管源性 病毒病因学,诊 断,AAO-HNS CHE 1985,Menieres is diagnosed by Vertigo Spontaneous, lasting minutes to hours Recurrent, must have more than 1 episode Associated with nystagmus Hearing loss Fluctuating sensorineural Low-frequency or flat Tinnitus Vertigo treatment reporting standard 0 = Complete control 1-40 = Substantial control 41-80 = Limited control 81-120 = Insignificant control 120 = Worse Hearing treatment reporting standard PTA reported 500, 1000, 2000, 3000 kHz If multiple pre and post levels are available, the worst is always used PTA is considered improved / worse if a 10 dB difference is noted SDS is considered improved / worse if a 15% difference is noted,AAO-HNS CHE 1995,Menieres is diagnosed by Vertigo Spontaneous, lasting minutes to hours Recurrent, must have 2 episodes 20 min. Nystagmus during episodes Hearing loss Avg (250, 500, 1000) 15 dB than other ear For bilateral disease Avg (500, 1000, 2000, 3000) 25 dB in the studied ear Tinnitus No guidelines Aural pressure No guidelines,AAO-HNS CHE 1995,Possible Menieres disease Episodic vertigo of the Menieres type without documented hearing loss, or Sensorineural hearing loss, fluctuating or fixed, with dysequilibrium but without definitive episodes Other causes excluded Probable Menieres disease One definitive episode of vertigo Audiometrically documented hearing loss on at least one occasion Tinnitus or aural fullness in the treated ear Other causes excluded Definite Menieres disease Two or more definitive spontaneous episodes of vertigo 20 minutes or longer Audiometrically documented hearing loss on at least one occasion Tinnitus or aural fullness in the treated ear Other cases excluded See staging chart Certain Menieres disease Definite Menieres disease, plus histopathologic confirmation See staging chart,AAO-HNS CHE 1995,Functional Level Scale Regarding my current state of overall function, not just during attacks (check the ONE that best applies): My dizziness has no effect on my activities at all. When I am dizzy I have to stop what I am doing for a while, but it soon passes and I can resume activities. I continue to work, drive, and engage in any activity I choose without restriction. I have not changed any plans or activities to accommodate my dizziness. When I am dizzy, I have to stop what I am doing for a while, but it does pass and I can resume activities. I continue to work, drive, and engage in most activities I choose, but I have had to change some plans and make some allowance for my dizziness. I am able to work, drive, travel, take care of a family, or engage in most essential activities, but I must exert a great deal of effort to do so. I must constantly make adjustments in my activities and budge my energies. I am barely making it. I am unable to work, drive, or take care of a family. I am unable to do most of the active things that I used to. Even essential activities must be limited. I am disabled. I have been disabled for 1 year or longer and/or I receive compensation (money) because of my dizziness or balance problem.,AAO-HNS CHE 1995,Reporting Results of Treatment: Vertigo treatment reporting standard A = 0 B = 1-40 C = 41-80 D = 81-120 E 120 F = Secondary treatment required due to disabling vertigo Hearing treatment reporting standard PTA reported 500, 1000, 2000, 3000 kHz If multiple pre and post levels are available, the worst is always used PTA is considered improved / worse if a 10 dB difference is noted SDS is considered improved / worse if a 15% difference is noted,鉴别诊断,迷路炎 有中耳炎病史 中耳内耳手术外伤史 瘘管试验阳性 耳药物中毒 有耳毒性药物应用史 如链霉素、庆大霉素等,前庭神经元炎 有上感病史、不伴耳蜗症状 眩晕2周 听神经瘤 单侧进行性耳聋耳鸣 眩晕轻 可伴三叉神经症状 突发性耳聋 突发严重感音性聋，单耳，伴或不伴眩晕 眩晕能恢复，听力恢复慢，或不能完全恢复,椎基底动脉供血不足 可和头位、活动有关 可伴有其他颅神经症状 椎基底动脉MRA异常 位置性眩晕 头处于某一个特定位置时出现眩晕 持续约数十秒 不伴耳鸣和耳聋。,药物治疗,血管扩张剂,血管扩张剂 减少内耳局部缺血，改善内淋巴代谢 倍他司汀：最常用，可减少眩晕 抗组胺药：作用机制存在争议 Meta分析 (2004) 仅一项Grade B、四项Grade C 研究, 无一项的结果令人信服,利 尿 药,Klockoff and Lindblom (1967) HCTZ vs.安慰剂在30位患者中的研究表明利尿疗法有效 Klockoff (1974) 76%患者氯噻酮治疗（疗程7年）有效 Shinkawa/Kimura (1986) 内淋巴积液的动物模型上无明显疗效 Ruckenstein (1991) 分析表明疗效无有意义改变 安慰剂有效50%,利尿药,渗透性利尿药(尿素,甘油) 口味不佳 部分患者中症状持续减轻，但疗效仅持续数小时 耳蜗电图描记：SP:AP 改变 乙酰唑胺 静脉给药加重积液和听力损失 (Brookes) 口服给药改善积液 (Shinkawa) 副作用：代谢性酸中毒和肾结石 (Brookes),Meniett 装置,经中耳腔的“Micropressure” 治疗 1999年 FDA 认证为 II类装置 自我治疗，TID 每次治疗3个1分钟 间歇应用，压力范围：0-20 cm H20 需要鼓膜通气管,Meniett 装置,Gates GA, Green JD. (2002) 设计：前瞻性研究, 10 例, 3-10月 眩晕 90% 完全控制 10% 减轻一半 问题 置管, 耳漏, 阻塞, 排出 治疗停止后复发 Densert and Sass (2001) 设计：前瞻性, 37例, 2年 眩晕 控制 51% 改善41% 失败 8%,鼓室内给药治疗,鼓室内地塞米松,糖皮质激素之作用,抑制免疫介导的炎性反应 增加耳蜗血流 增进耳蜗稳态,2019/8/6,25,可编辑,鼓室内地塞米松,优点 直接用药 内耳内高浓度 较少副作用 糖尿病、高血压、溃疡患者均可用 不会导致听力损失 疾病早期疗效显著,化学性迷路切除,Fowler (1948) and Schuknecht (1957) 确定氨基糖甙疗效 原来：链霉素 所有病人眩晕控制 所有病人重度聋 现在：庆大霉素 理论治疗目标 血管纹的暗细胞 半规管的半月板 大剂量损伤耳蜗毛细胞,鼓室内庆大霉素,庆大霉素首选：作用位点位于血管纹 副作用: 暂时性平衡失调，眼球震颤 听力损失 耳鸣,方法 注射 放置明胶海绵 Microwick 鼓室内多次给药 小剂量 每周一次 一日多次 连续给药 滴定法,手术治疗,内淋巴囊手术,1927年法国Portmann首创 1954年Yamakawa和Naito改进，内淋巴囊和脑脊液之间分流 Willium House普及手术显微镜和现代耳科技术，切开引流处放置Teflon管 1966年Shea将Teflon引流条置于内淋巴囊和乳突之间 1975年Stahle和1976年Arenberg内耳活瓣内淋巴囊内硅树脂单向活瓣，延伸到乳突腔,内淋巴囊手术方法,内淋巴囊减压术 内淋巴囊分流术 乳突分流 蛛网膜下腔分流,内淋巴囊手术适应症,低频听力损失30dB以下，发作型梅尼埃病，保守治疗无效 难治性梅尼埃病 双耳梅尼埃病,内淋巴囊手术禁忌症,患耳为唯一听力耳（慎用） 中晚期患者，听力损失严重 严重内耳畸形、Mondini畸形、大前庭导水管综合症 中耳炎,前庭神经切断术,手术径路 乙状窦后径路 迷路后径路 颅中窝径路 迷路下径路,前庭神经切断术手术适应症,严重眩晕，发作频繁，患耳听力尚好，保守治疗超过6个月或内淋巴囊手术无效 迷路破坏后仍有眩晕，并有残留迷路功能 外伤性、突发性聋、中耳手术所致的持续性眩晕，保守治疗无效 复发性前庭神经炎,前庭神经切断